Use of Moisturizers and Lubricants for Vulvovaginal Atrophy [PDF]
The estrogen decrease in postmenopausal women results in functional and anatomical changes in the genitourinary tract. The most prevalent and bothersome symptoms are vaginal dryness, dyspareunia, and reduced lubrication, which can significantly affect ...
Pedro Vieira-Baptista +2 more
exaly +8 more sources
Hormonal Approach for Postmenopausal Vulvovaginal Atrophy [PDF]
Menopause is a physiological and progressive phenomenon secondary to decreased ovarian follicular reserve that significantly affects the genital tract. Although postmenopausal vulvovaginal atrophy primarily affects postmenopausal women, it is also seen ...
Ana Paula Ferreira Costa +7 more
doaj +6 more sources
GRACE-trial: a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy – study protocol [PDF]
Introduction Breast cancer is the most common cancer type in women worldwide. Due to hormone receptor positivity in the majority of the breast cancer tumours is endocrine therapy a crucial part in the treatment landscape of breast cancer.
Glenn Vergauwen +6 more
doaj +2 more sources
Vulvovaginal Atrophy Following Treatment for Oncogynecologic Pathologies: Etiology, Epidemiology, Diagnosis, and Treatment Options [PDF]
Vulvovaginal atrophy, characterized by the thinning of vaginal mucosa typically resulting from reduced estrogen levels, is frequently exacerbated by oncogynecologic treatments such as chemotherapy, hormonal therapy, radiotherapy, or surgery.
Ramunė Narutytė +2 more
doaj +2 more sources
Fractional CO2 Laser for Treatment of Vulvovaginal Atrophy: A Short Time Follow-up [PDF]
Objective: The aim of this study was to evaluate the safety and efficacy of fractional CO2 laser for treatment of vulvovaginal atrophy. Materials and methods: In this clinical trial study, we evaluated the laser effect on vulvovaginal atrophy in 47 women
Zinat Ghanbari +6 more
doaj +2 more sources
Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause [PDF]
The effects of oral vitamin D supplements on vaginal health in postmenopausal women with vulvovaginal atrophy (VVA) was evaluated. A double-blinded, randomized placebo-controlled trial was conducted for 12 weeks to investigate changes on vaginal maturation index (VMI), vaginal pH, and the visual analog scale (VAS) of VVA symptoms.
Jittima Manonai +2 more
exaly +5 more sources
Comment on Jankovic et al. Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. Medicina 2024, 60, 1059 [PDF]
We write with concerns regarding the recent publication of “Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy” [...]
Catherine Broomfield +2 more
doaj +2 more sources
Topical Spermidine Hyaluronate (Spd-HA) in Vulvovaginal Atrophy: A Preliminary Study [PDF]
Background and Objectives: Genitourinary syndrome of menopause (GSM), previously termed vulvovaginal atrophy (VVA), is a prevalent hypoestrogenic condition characterized by genital, sexual, and urinary symptoms. Although hormonal therapies are effective,
Irene Porcari +9 more
doaj +2 more sources
Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study [PDF]
Introduction: The prevalence of menopausal women with confirmed vulvovaginal atrophy (VVA) oscillates between 67–98%. Aim: To assess the prevalence of postmenopausal women with VVA confirmed by gynecologic clinical assessment among all women attending ...
Santiago Palacios, MD, PhD +27 more
doaj +2 more sources
Vulvovaginal atrophy in postmenopausal women: diagnosis and modern-day treatments
The article is devoted to the study of modern methods of diagnosis and treatment of benign diseases of the vulva and vagina in postmenopausal women.
K. R. Bahtiyarov +2 more
doaj +1 more source

